Blue Capital Inc. Takes Position in CVS Health Corporation $CVS

Blue Capital Inc. purchased a new position in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 5,819 shares of the pharmacy operator’s stock, valued at approximately $602,000.

A number of other large investors have also bought and sold shares of the stock. Caitong International Asset Management Co. Ltd raised its position in CVS Health by 407.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 281 shares during the last quarter. Swiss RE Ltd. bought a new stake in shares of CVS Health in the 4th quarter worth approximately $26,000. Kilter Group LLC purchased a new position in shares of CVS Health during the second quarter valued at approximately $27,000. Sankala Group LLC bought a new position in shares of CVS Health during the fourth quarter valued at approximately $28,000. Finally, Global Trust Asset Management LLC lifted its stake in CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 300 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on CVS shares. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a research report on Thursday, August 6th. Bank of America lifted their target price on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Royal Bank Of Canada boosted their price target on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. Finally, DA Davidson lifted their price objective on CVS Health from $80.00 to $100.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Stock Down 0.7%

CVS stock opened at $93.01 on Friday. The stock has a market capitalization of $118.96 billion, a P/E ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The business has a fifty day moving average price of $102.02 and a 200-day moving average price of $88.86.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period last year, the company earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. CVS Health’s dividend payout ratio is 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.